SCHEMBL3974199

SCHEMBL3974199

COc1ccc(C(=O)NNC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)cc1Cl

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
KMT2A Q03164 4/20 0.59
LMNA P02545 2/20 0.59
MEN1 O00255 3/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HTT P42858 2/20 0.52
KCNH2 Q12809 1/20 0.52
MAPT P10636 5/20 0.46
KDM4E B2RXH2 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP3A4 P08684 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
ALOX12 P18054 1/20 0.44
TAS1R3 Q7RTX0 3/20 0.43
TAS1R1 Q7RTX1 3/20 0.43
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978634 0.90 CYP3A4 (0.56) ALDH1A1KMT2ALMNAMEN1NPC1
SCHEMBL3974631 0.90 CTSA (0.47) ALDH1A1KMT2ALMNAMEN1HTT
SCHEMBL3976996 0.87 L3MBTL1 (0.51) ALDH1A1KMT2ALMNAMEN1MAPT
SCHEMBL3978024 0.87 CYP3A4 (0.45) ALDH1A1KMT2ALMNAMEN1NPC1
SCHEMBL3982336 0.87 LMNA (0.47) ALDH1A1KMT2ALMNAMEN1NPC1
SCHEMBL3983006 0.87 ALDH1A1 (0.58) ALDH1A1KMT2ALMNAMEN1HTT
SCHEMBL3977741 0.86 GCGR (0.49) ALDH1A1KMT2ALMNAMEN1RAB9A
SCHEMBL3979538 0.84 ALDH1A1 (0.49) ALDH1A1KMT2ALMNAMEN1HTT
SCHEMBL3978777 0.84 CYP3A4 (0.43) ALDH1A1KMT2ALMNAMEN1HTT
SCHEMBL3982131 0.84 KMT2A (0.40) ALDH1A1KMT2ALMNAMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALDH1A1 1389/4885KMT2A 3459/4885LMNA 2180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.